Inhibition of Breast Cancer Cell Motility With a Non-Cyclooxygenase Inhibitory Derivative of Sulindac by Suppressing TGFβ/miR-21 Signaling
Oncotarget - United States
doi 10.18632/oncotarget.6888
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 12, 2016
Authors
Publisher
Impact Journals, LLC